Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death рецептор-1 (PD-1) моноклональный IgG4 антитело that blocks PD-1/PD-L1-mediated T-клетка suppression. Cemiplimab is commonly used in squamous клетка skin cancer research.
Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death receptor-1 (PD-1) monoclonal IgG4 antibody that blocks PD-1/PD-L1-mediated T-cell suppression. Cemiplimab is commonly used in squamous cell skin cancer research.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.